| Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre … APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ... The Lancet 398 (10318), 2258-2276, 2021 | 673 | 2021 |
| Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial M Dennis, G Mead, J Forbes, C Graham, M Hackett, GJ Hankey, A House, ... The Lancet 393 (10168), 265-274, 2019 | 280 | 2019 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 223 | 2022 |
| CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia KL Williams, S Topp, S Yang, B Smith, JA Fifita, ST Warraich, KY Zhang, ... Nature communications 7 (1), 11253, 2016 | 221 | 2016 |
| Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a … APS Munro, S Feng, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, ... The Lancet Infectious Diseases 22 (8), 1131-1141, 2022 | 138 | 2022 |
| A Tol2 gateway-compatible toolbox for the study of the nervous system and neurodegenerative disease EK Don, I Formella, AP Badrock, TE Hall, M Morsch, E Hortle, A Hogan, ... Zebrafish 14 (1), 69-72, 2017 | 60 | 2017 |
| Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype AL Hogan, EK Don, SL Rayner, A Lee, AS Laird, M Watchon, C Winnick, ... Human molecular genetics 26 (14), 2616-2626, 2017 | 46 | 2017 |
| Real-time visualization of oxidative stress-mediated neurodegeneration of individual spinal motor neurons in vivo I Formella, AJ Svahn, RAW Radford, EK Don, NJ Cole, A Hogan, A Lee, ... Redox Biology 19, 226-234, 2018 | 40 | 2018 |
| Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord BG Trist, S Genoud, S Roudeau, A Rookyard, A Abdeen, V Cottam, ... Brain 145 (9), 3108-3130, 2022 | 34 | 2022 |
| Cyclin F: a component of an E3 ubiquitin ligase complex with roles in neurodegeneration and cancer J Galper, SL Rayner, AL Hogan, JA Fifita, A Lee, RS Chung, IP Blair, ... The international journal of biochemistry & cell biology 89, 216-220, 2017 | 33 | 2017 |
| Genetic and pathological assessment of hnRNPA1, hnRNPA2/B1, and hnRNPA3 in familial and sporadic amyotrophic lateral sclerosis JA Fifita, KY Zhang, J Galper, KL Williams, EP McCann, AL Hogan, ... Neurodegenerative Diseases 17 (6), 304-312, 2017 | 32 | 2017 |
| ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ SL Rayner, F Cheng, AL Hogan, N Grima, S Yang, YD Ke, CG Au, ... Human Molecular Genetics 30 (11), 971-984, 2021 | 21 | 2021 |
| Motor neuron abnormalities correlate with impaired movement in zebrafish that express mutant superoxide dismutase 1 KJ Robinson, KC Yuan, EK Don, AL Hogan, CG Winnick, MC Tym, ... Zebrafish 16 (1), 8-14, 2019 | 18 | 2019 |
| Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration BG Trist, JA Fifita, A Hogan, N Grima, B Smith, C Troakes, C Vance, ... Acta Neuropathologica Communications 10 (1), 122, 2022 | 17 | 2022 |
| Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open … O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 401 (10387), 1499-1507, 2023 | 16 | 2023 |
| Unbiased Label-Free Quantitative Proteomics of Cells Expressing Amyotrophic Lateral Sclerosis (ALS) Mutations in CCNF Reveals Activation of the Apoptosis … F Cheng, A De Luca, AL Hogan, SL Rayner, JM Davidson, M Watchon, ... Frontiers in Molecular Neuroscience 14, 627740, 2021 | 14 | 2021 |
| Splicing factor proline and glutamine rich intron retention, reduced expression and aggregate formation are pathological features of amyotrophic lateral sclerosis AL Hogan, N Grima, JA Fifita, EP McCann, B Heng, SCM Fat, S Wu, ... Neuropathology and Applied Neurobiology 47 (7), 990-1003, 2021 | 12 | 2021 |
| Flow cytometry allows rapid detection of protein aggregates in cellular and zebrafish models of spinocerebellar ataxia 3 KJ Robinson, MC Tym, A Hogan, M Watchon, KC Yuan, SK Plenderleith, ... Disease Models & Mechanisms 14 (10), dmm049023, 2021 | 10 | 2021 |
| Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice EP McCann, JA Fifita, N Grima, J Galper, P Mehta, SE Freckleton, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (2), 162-171, 2020 | 10 | 2020 |
| Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet Diabetes & Endocrinology 11 (12), 905-914, 2023 | 8 | 2023 |
